Aardvark Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 1.36 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 29.76M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.